Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
18.98
-0.85 (-4.31%)
Nov 5, 2025, 11:23 AM EST - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.05 billion as of November 5, 2025. Its market cap has increased by 21.52% in one year.
Market Cap
2.05B
Enterprise Value
1.43B
1-Year Change
21.52%
Ranking
Category
Stock Price
$18.98
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.05B, an increase of 190.81%. That is a compound annual growth rate of 14.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 2.14B | 57.13% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |